← SynDRA
TELAPREVIR
SynDRA canonical compound SYN0007572 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | CTSA | PGR |
|---|
| Mechanism of action | HCV inhibitor |
|---|
| Indication | hepatitis C |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CTSA
- CELA1
- CMA1
- CTSB
- CTSK
- CTSL
- CTSS
- CTSV
- ELANE
- HCV NS3/4A
- NS3
- NS4A
Mechanisms of action (all sources)
- HCV inhibitor
- HCV NS3/4A MODULATOR
- NS3 INHIBITOR
- NS4A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- F2
- ADORA1
- HRH1
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PRSS1
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH2
- HDAC6
- ADORA2A
- BDKRB2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- ADRB3
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- HCV NS3/4A Protease Inhibitors
- Hepatitis C Virus NS3/4A Protease Inhibitor
- P-Glycoprotein Inhibitors
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 2B1 Inhibitors
- Cytochrome P450 3A Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- INCIVEK
- VX 950
- incivek
- incivo
- LY-570310
- MP-424
- VRT-111950
- VX-950
- Incivek
- Incivo
- Telaprevir (VX-950)
- Telavic
- VX-950(Telaprevir)
- UNII-655M5O3W0U
- CHEMBL231813
- CHEBI:68595
- 655M5O3W0U
- S-Telaprevir
- MP 424
- LY 570310
- VX950 cpd
- telaprevirum
- RefChem:56918
- DTXCID10115795
- J05AP02
- MFCD11616089
- Telaprevir [USAN:INN]
- VX950
- HSDB 8125
- Incivek(TM)
- Incivek (TN)
- Incivo (TN)
- Telaprevir,VX-950
- A1DIB
- TELAPREVIR [MI]
- TELAPREVIR [INN]
- TELAPREVIR [JAN]
- TELAPREVIR [USAN]
Look up TELAPREVIR in the interactive SynDRA portal →